Octreotide Acetate Drug Interactions: 9 Major, 347 Moderate
Octreotide Acetate Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Octreotide Acetate. Always confirm against the full prescribing information.
100 interactions
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Octreotide.
Level 1 evidence
Acalabrutinib
The serum concentration of Acalabrutinib can be increased when it is combined with Octreotide.
Level 1 evidence
Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Octreotide.
Level 1 evidence
Acebutolol
The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Acebutolol.
Level 1 evidence
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Octreotide.
Level 1 evidence
Albendazole
The metabolism of Albendazole can be decreased when combined with Octreotide.
Level 2 evidence
Alectinib
The serum concentration of Alectinib can be increased when it is combined with Octreotide.
Level 1 evidence
Alfentanil
The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Alfentanil.
Level 1 evidence
Alfuzosin
The metabolism of Alfuzosin can be decreased when combined with Octreotide.
Level 1 evidence
Almasilate
Almasilate can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Alogliptin
The therapeutic efficacy of Alogliptin can be decreased when used in combination with Octreotide.
Level 1 evidence
Alpelisib
The serum concentration of Alpelisib can be increased when it is combined with Octreotide.
Octreotide Acetate has 789 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Octreotide Acetate has 9 major, 347 moderate, and 433 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Octreotide Acetate. Always confirm against the full prescribing information.